{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:53:44Z","timestamp":1790744024940,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T00:00:00Z","timestamp":1361318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Osteoporosis mainly affects postmenopausal women and older men. Gastrointestinal hormones released after meal ingestion, such as glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide (GLP)-2, have been shown to regulate bone turnover. However, whether GLP-1, another important gastrointestinal hormone, and its analogues also have antiosteoporotic effects, especially in aged postmenopausal situation, has not been confirmed. In the present study, we evaluated the effects of the GLP-1 receptor agonist exendin-4 on ovariectomy (OVX)-induced osteoporosis in old rats. Twelve-month-old female Sprague-Dawley rats were subjected to OVX, and exendin-4 was administrated 4 weeks after the surgery and lasted for 16 weeks. Bone characters and related serum and gene biomarkers were analyzed. Sixteen weeks of treatment with exendin-4 slowed down body weight gain by decreasing fat mass and prevented the loss of bone mass in old OVX rats. Exendin-4 also enhanced bone strength and prevented the deterioration of trabecular microarchitecture. Moreover, exendin-4 decreased the urinary deoxypyridinoline (DPD)\/creatinine ratio and serum C-terminal cross-linked telopeptides of type I collagen (CTX-I) and increased serum alkaline phosphatase (ALP), osteocalcin (OC), and N-terminal propeptide of type 1 procollagen (P1NP) levels, key biochemical markers of bone turnover. Interestingly, gene expression results further showed that exendin-4 not only inhibited bone resorption by increasing the osteoprotegerin (OPG)\/receptor activator of NF-\u03baB ligand (RANKL) ratio, but also promoted bone formation by increasing the expression of OC, Col1, Runx2, and ALP, which exhibited dual regulatory effects on bone turnover as compared with previous antiosteoporotic agents. In conclusion, these findings demonstrated for the first time the antiosteoporotic effects of exendin-4 in old OVX rats and that it might be a potential candidate for treatment of aged postmenopausal osteoporosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.1898","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T21:25:09Z","timestamp":1361395509000},"page":"1641-1652","source":"Crossref","is-referenced-by-count":189,"title":["Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats"],"prefix":"10.1093","volume":"28","author":[{"given":"Xue","family":"Ma","sequence":"first","affiliation":[{"name":"Department of PharmacologySchool of Pharmacy, Fourth Military Medical UniversityXi'anChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of PharmacologySchool of Pharmacy, Fourth Military Medical UniversityXi'anChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of PharmacologySchool of Pharmacy, Fourth Military Medical UniversityXi'anChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Bi","sequence":"additional","affiliation":[{"name":"Institute of Orthopaedics and TraumatologyXijing Hospital, Fourth Military Medical UniversityXi'anChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of PharmacologySchool of Pharmacy, Fourth Military Medical UniversityXi'anChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of PharmacologySchool of Pharmacy, Fourth Military Medical UniversityXi'anChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Histology and EmbryologyFourth Military Medical UniversityXi'anChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonghao","family":"He","sequence":"additional","affiliation":[{"name":"Department of PharmacyKunming General Hospital of Chengdu Military RegionKunmingChina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of PharmacologySchool of Pharmacy, Fourth Military Medical UniversityXi'anChina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,2,20]]},"reference":[{"issue":"4","key":"2024020318375757600_jbmr1898-bib-0001","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11357-008-9069-9","article-title":"Age-dependent Wnt gene expression in bone and during the course of osteoblast differentiation","volume":"30","author":"Rauner","year":"2008","journal-title":"Age (Dordr)."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0002","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/jc.2007-0042","article-title":"Update in osteoporosis and metabolic bone disorders","volume":"92","author":"Shoback","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2024020318375757600_jbmr1898-bib-0003","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1210\/jc.2011-2332","article-title":"Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives","volume":"97","author":"Baron","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/B:REMD.0000032415.83124.20","article-title":"Osteoporosis and diabetes mellitus","volume":"5","author":"Inzerillo","year":"2004","journal-title":"Rev Endocr Metab Disord."},{"issue":"6","key":"2024020318375757600_jbmr1898-bib-0006","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S8756-3282(02)00728-7","article-title":"Effect of feeding on bone turnover markers and its impact on biological variability of measurements","volume":"30","author":"Clowes","year":"2002","journal-title":"Bone."},{"issue":"9","key":"2024020318375757600_jbmr1898-bib-0007","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1359\/JBMR.050524","article-title":"Potential role of pancreatic and enteric hormones in regulating bone turnover","volume":"20","author":"Clowes","year":"2005","journal-title":"J Bone Miner Res."},{"issue":"12","key":"2024020318375757600_jbmr1898-bib-0008","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1359\/jbmr.2003.18.12.2180","article-title":"Role of gastrointestinal hormones in postprandial reduction of bone resorption","volume":"18","author":"Henriksen","year":"2003","journal-title":"J Bone Miner Res."},{"issue":"10","key":"2024020318375757600_jbmr1898-bib-0009","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1463-1326.2009.01070.x","article-title":"Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation","volume":"11","author":"Ma","year":"2009","journal-title":"Diabetes Obes Metab."},{"issue":"4","key":"2024020318375757600_jbmr1898-bib-0010","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0011","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2007-1292","article-title":"The murine glucagon-like peptide-1 receptor is essential for control of bone resorption","volume":"149","author":"Yamada","year":"2008","journal-title":"Endocrinology."},{"issue":"1\u20133","key":"2024020318375757600_jbmr1898-bib-0012","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2009.06.010","article-title":"Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states","volume":"159","author":"Nuche-Berenguer","year":"2010","journal-title":"Regul Pept."},{"issue":"6","key":"2024020318375757600_jbmr1898-bib-0013","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.tem.2007.06.005","article-title":"Incretin-based therapies: mimetics versus protease inhibitors","volume":"18","author":"Brubaker","year":"2007","journal-title":"Trends Endocrinol Metab."},{"issue":"4","key":"2024020318375757600_jbmr1898-bib-0014","first-page":"401","article-title":"Pharmacology of exenatide (synthetic exendin-4) for the treatment of type 2 diabetes","volume":"4","author":"Nielsen","year":"2003","journal-title":"Curr Opin Investig Drugs."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2337\/diabetes.53.3.654","article-title":"Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects","volume":"53","author":"Meier","year":"2004","journal-title":"Diabetes."},{"issue":"9786","key":"2024020318375757600_jbmr1898-bib-0016","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0017","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajhp\/62.2.173","article-title":"Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus","volume":"62","author":"Kolterman","year":"2005","journal-title":"Am J Health Syst Pharm."},{"issue":"10","key":"2024020318375757600_jbmr1898-bib-0018","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/s-2005-870529","article-title":"Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes","volume":"37","author":"Taylor","year":"2005","journal-title":"Horm Metab Res."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0019","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02106092","article-title":"Specific evaluation of localized bone mass and bone loss in the rat using dual-energy X-ray absorptiometry subregional analysis","volume":"5","author":"Pastoureau","year":"1995","journal-title":"Osteoporos Int."},{"issue":"6","key":"2024020318375757600_jbmr1898-bib-0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1359\/jbmr.090101","article-title":"Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing","volume":"24","author":"Taylor","year":"2009","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2024020318375757600_jbmr1898-bib-0021","first-page":"348","article-title":"Nutritional hormones and the entero-osseous axis","volume":"8","author":"Isales","year":"2008","journal-title":"J Musculoskelet Neuronal Interact."},{"key":"2024020318375757600_jbmr1898-bib-0022","doi-asserted-by":"crossref","first-page":"519784","DOI":"10.1155\/2012\/519784","article-title":"Bone: incretin hormones perceiver or receiver?","volume":"2012","author":"Dicembrini","year":"2012","journal-title":"Exp Diabetes Res."},{"issue":"1","key":"2024020318375757600_jbmr1898-bib-0023","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bone.2003.09.009","article-title":"Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2","volume":"34","author":"Henriksen","year":"2004","journal-title":"Bone."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0024","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bone.2006.09.025","article-title":"Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women","volume":"40","author":"Henriksen","year":"2007","journal-title":"Bone."},{"issue":"5","key":"2024020318375757600_jbmr1898-bib-0025","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bone.2009.07.008","article-title":"Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD","volume":"45","author":"Henriksen","year":"2009","journal-title":"Bone."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0027","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1359\/jbmr.071108","article-title":"Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women","volume":"23","author":"Boutroy","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0028","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s001980200000","article-title":"Biomechanics of bone: determinants of skeletal fragility and bone quality","volume":"13","author":"Turner","year":"2002","journal-title":"Osteoporos Int."},{"issue":"9","key":"2024020318375757600_jbmr1898-bib-0029","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1359\/jbmr.2001.16.9.1674","article-title":"Effect of 16 months of treatment with tibolone on bone mass, turnover, and biomechanical quality in mature ovariectomized rats","volume":"16","author":"Ederveen","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"6","key":"2024020318375757600_jbmr1898-bib-0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF02556007","article-title":"Long-term effects of ovariectomy and aging on the rat skeleton","volume":"45","author":"Wronski","year":"1989","journal-title":"Calcif Tissue Int."},{"key":"2024020318375757600_jbmr1898-bib-0031","first-page":"3","article-title":"Calcium and phosphate homeostasis: concerted interplay of new regulators","volume":"34","author":"Civitelli","year":"2011","journal-title":"J Endocrinol Invest."},{"issue":"6","key":"2024020318375757600_jbmr1898-bib-0032","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-009-9220-3","article-title":"Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states","volume":"84","author":"Nuche-Berenguer","year":"2009","journal-title":"Calcif Tissue Int."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0033","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/JOE-11-0015","article-title":"GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia","volume":"209","author":"Nuche-Berenguer","year":"2011","journal-title":"J Endocrinol."},{"issue":"4","key":"2024020318375757600_jbmr1898-bib-0034","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation","volume":"151","author":"Bjerre Knudsen","year":"2010","journal-title":"Endocrinology."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/ENDO:21:3:201","article-title":"Is calcitonin an important physiological substance?","volume":"21","author":"Hirsch","year":"2003","journal-title":"Endocrine."},{"issue":"5","key":"2024020318375757600_jbmr1898-bib-0036","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell."},{"key":"2024020318375757600_jbmr1898-bib-0037","first-page":"8","article-title":"Markers of bone turnover: biochemical and clinical perspectives","volume":"28","author":"Pagani","year":"2005","journal-title":"J Endocrinol Invest."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0039","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1210\/jc.2010-1922","article-title":"Bone marrow fat is inversely related to cortical bone in young and old subjects","volume":"96","author":"Wren","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2024020318375757600_jbmr1898-bib-0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1359\/jbmr.2003.18.1.140","article-title":"Tower climbing exercise started 3 months after ovariectomy recovers bone strength of the femur and lumbar vertebrae in aged osteopenic rats","volume":"18","author":"Notomi","year":"2003","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024020318375757600_jbmr1898-bib-0041","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1359\/jbmr.070813","article-title":"Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis","volume":"23","author":"Zhao","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0042","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/jbmr.091004","article-title":"Obesity and fractures in postmenopausal women","volume":"25","author":"Premaor","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0043","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1161\/01.ATV.0000112023.62695.7f","article-title":"Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo","volume":"24","author":"Tintut","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"1","key":"2024020318375757600_jbmr1898-bib-0044","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11883-001-0008-9","article-title":"Statins, hormones, and women: benefits and drawbacks for atherosclerosis and osteoporosis","volume":"3","author":"Herrington","year":"2001","journal-title":"Curr Atheroscler Rep."},{"issue":"1","key":"2024020318375757600_jbmr1898-bib-0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S8756-3282(02)00918-3","article-title":"Does serum cholesterol contribute to vertebral bone loss in postmenopausal women?","volume":"32","author":"Tanko","year":"2003","journal-title":"Bone."},{"issue":"8","key":"2024020318375757600_jbmr1898-bib-0046","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/dc09-2062","article-title":"Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database","volume":"33","author":"Horton","year":"2010","journal-title":"Diabetes Care."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0047","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1210\/endo.141.3.7366","article-title":"Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors","volume":"141","author":"Bollag","year":"2000","journal-title":"Endocrinology."},{"issue":"9","key":"2024020318375757600_jbmr1898-bib-0048","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/jbmr.424","article-title":"Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes","volume":"26","author":"Gharibi","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024020318375757600_jbmr1898-bib-0049","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.bone.2011.06.030","article-title":"New factors controlling the balance between osteoblastogenesis and adipogenesis","volume":"50","author":"Abdallah","year":"2012","journal-title":"Bone."},{"issue":"3","key":"2024020318375757600_jbmr1898-bib-0050","doi-asserted-by":"crossref","first-page":"E634","DOI":"10.1152\/ajpendo.00460.2009","article-title":"Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow","volume":"298","author":"Sanz","year":"2010","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"9","key":"2024020318375757600_jbmr1898-bib-0051","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","article-title":"Thiazolidinedione use and bone loss in older diabetic adults","volume":"91","author":"Schwartz","year":"2006","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1898","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/7\/1641\/56563618\/jbmr1898.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/28\/7\/1641\/56563618\/jbmr1898.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:48:55Z","timestamp":1710341335000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/28\/7\/1641-1652\/7598690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,20]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,2,20]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1898","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,7,1]]},"published":{"date-parts":[[2013,2,20]]}}}